Last reviewed · How we verify
HEC83518
At a glance
| Generic name | HEC83518 |
|---|---|
| Sponsor | Sunshine Lake Pharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects (PHASE1)
- The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects (PHASE1)
- the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HEC83518 CI brief — competitive landscape report
- HEC83518 updates RSS · CI watch RSS
- Sunshine Lake Pharma Co., Ltd. portfolio CI